Diagnostic ureterorenoscopy is associated with increased intravesical recurrence following radical nephroureterectomy in upper tract Urothelial Carcinoma

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Sung, Hyun Hwan ^a   Jeon, Hwang Gyun ^a   Han, Deok Hyun ^a   Jeong, Byong Chang ^a   Seo, Seong Il ^a   Lee, Hyun Moo ^a   Choi, Han Yong ^a   Jeon, Seong Soo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; PREDICTION; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA; TUMOR BIOPSY; URETERORENOSCOPY; ADVERSE EFFECTS; CARCINOMA, TRANSITIONAL CELL; DISEASE FREE SURVIVAL; ETIOLOGY; KAPLAN MEIER METHOD; MIDDLE AGED; NEPHRECTOMY; PATHOLOGY; PREOPERATIVE CARE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SECONDARY; TUMOR RECURRENCE; TUMOR SEEDING; URETER; URETERAL NEOPLASMS; URETEROSCOPY; URINARY BLADDER NEOPLASMS;

AGED; CARCINOMA, TRANSITIONAL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM SEEDING; NEPHRECTOMY; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; URETER; URETERAL NEOPLASMS; URETEROSCOPY; URINARY BLADDER NEOPLASMS;

EID: 84953406308     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139976     Document Type: Article

References (28)

1. Raman JD, Messer J, Sielatycki JA, Hollenbeak CS. Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005. BJU Int. 2011; 107: 1059-1064. doi: 10.1111/j. 1464-410X.2010.09675.x
2. Ristau BT, Tomaszewski JJ, Ost MC. Upper tract urothelial carcinoma: current treatment and outcomes. Urology. 2012; 79: 749-756. doi: 10.1016/j.urology.2011.12.024
3. Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester R, Burger M, et al. European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol. 2013; 63: 1059-1071. doi: 10.1016/j.eururo. 2013.03.032
4. Babjuk M, OosterlinckW, Sylvester R, Kaasinen E, Bohle A, Palou-Redorta J, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol. 2011; 59: 997-1008. doi: 10.1016/j.eururo.2011.03.017
5. Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, et al. Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009; 115: 1224-1233. doi: 10.1002/cncr.24135
6. Wu WJ, Ke HL, Yang YH, Li CC, Chou YH, Huang CH. Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy? J Urol. 2010; 183: 56-61. doi: 10.1016/j.juro.2009.08.154
7. O'Brien T, Ray E, Singh R, Coker B, Beard R. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: A prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). Eur Urol. 2011; 60: 703-710. doi: 10.1016/j.eururo.2011.05.064
8. Liu Y, Lu J, Hong K, Huang Y, Ma L. Independent prognostic factors for initial intravesical recurrence after laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma. Urol Oncol. 2014; 32: 146-152. doi: 10.1016/j.urolonc.2013.02.018
9. Luo HL, Kang CH, Chen YT, Chuang YC, Lee WC, Cheng YT, et al. Diagnostic ureteroscopy independently correlates with intravesical recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma. Ann Surg Oncol. 2013; 20: 3121-3126. doi: 10.1245/s10434-013-3000-z
10. Terakawa T, Miyake H, Muramaki M, Takenaka A, Hara I, Fujisawa M. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract. Urology. 2008; 71: 123-127. doi: 10.1016/j.urology.2007.08.054
11. Xylinas E, Kluth L, Passoni N, Trinh QD, Rieken M, Lee RK, et al. Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool. Eur Urol. 2014; 65: 650-658. doi: 10.1016/j.eururo.2013.09.003
12. Ishikawa S, Abe T, Shinohara N, Harabayashi T, Sazawa A, Maruyama S, et al. Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract. J Urol. 2010; 184: 883-887. doi: 10.1016/j.juro.2010.05.027
13. Kang CH, Yu TJ, Hsieh HH, Yang JW, Shu K, Huang CC, et al. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer. 2003; 98: 1620-1626.
14. Nison L, Roupret M, Bozzini G, Ouzzane A, Audenet F, Pignot G, et al. The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database. World J Urol. 2013; 31: 69-76. doi: 10.1007/s00345-012-0959-1
15. Azemar MD, Comperat E, Richard F, Cussenot O, Roupret M. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol. 2011; 29: 130-136. doi: 10.1016/j.urolonc.2009.06.003
16. Lughezzani G, Burger M, Margulis V, Matin SF, Novara G, Roupret M, et al. Prognostic factors in upper urinary tract urothelial carcinomas: A comprehensive review of the current literature. Eur Urol. 2012; 62: 100-114. doi: 10.1016/j.eururo.2012.02.030
17. Pignot G, Colin P, Zerbib M, Audenet F, Soulie M, Hurel S, et al. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma. Urol Oncol. 2014; 32: 23.e21-28.
18. Chromecki TF, Cha EK, Fajkovic H, Margulis V, Novara G, Scherr DS, et al. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol. 2012; 61: 245-253. doi: 10.1016/j.eururo.2011.09.017
19. Xylinas E, Colin P, Audenet F, Phe V, Cormier L, Cussenot O, et al. Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study. World J Urol. 2013; 31: 61-68. doi: 10.1007/s00345-012-0957-3
20. Allard CB, Alamri A, Dason S, Farrokhyar F, Matsumoto ED, Kapoor A. The method of bladder cuff excision during laparoscopic radical nephroureterectomy does not affect oncologic outcomes in upper tract urothelial carcinoma. World J Urol. 2013; 31: 175-181. doi: 10.1007/s00345-012-0915-0
21. Li WM, Shen JT, Li CC, Ke HL, Wei YC, Wu WJ, et al. Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma. Eur Urol. 2010; 57: 963-969. doi: 10.1016/j.eururo.2009.12.032
22. Xylinas E, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H, et al. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol. 2014; 65: 210-217. doi: 10.1016/j.eururo.2012.04.052
23. Kume H, Teramoto S, Tomita K, Nishimatsu H, Takahashi S, Takeuchi T, et al. Bladder recurrence of upper urinary tract cancer after laparoscopic surgery. J Surg Oncol. 2006; 93: 318-322.
24. Hanna N, Sun M, Trinh QD, Hansen J, Bianchi M, Montorsi F, et al. Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: A national series. Eur Urol. 2012; 61: 715-721. doi: 10.1016/j.eururo.2011.12.026
25. Hattori R, Yoshino Y, Gotoh M, Katoh M, Kamihira O, Ono Y. Laparoscopic nephroureterectomy for transitional cell carcinoma of renal pelvis and ureter: Nagoya experience. Urology. 2006; 67: 701-705.
26. Ni S, Tao W, Chen Q, Liu L, Jiang H, Hu H, et al. Laparoscopic versus open nephroureterectomy for the treatment of upper urinary tract urothelial carcinoma: A systematic review and cumulative analysis of comparative studies. Eur Urol. 2012; 61: 1142-1153. doi: 10.1016/j.eururo.2012.02.019
27. Zou L, Zhang L, Zhang H, Jiang H, Ding Q. Comparison of post-operative intravesical recurrence and oncological outcomes after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma. World J Urol. 2014; 32: 565-570.
28. Ito A, Shintaku I, Satoh M, Ioritani N, Aizawa M, Tochigi T, et al. Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: The THP Monotherapy Study Group Trial. J Clin Oncol. 2013; 31: 1422-1427. doi: 10.1200/JCO.2012.45.2128